메뉴 건너뛰기




Volumn 29, Issue , 2011, Pages 587-619

Immune response to dengue virus and prospects for a vaccine

Author keywords

antibody dependent enhancement; DENV; DHF DSS; immunization

Indexed keywords

AUTOANTIBODY; CHIMERIC VIRUS VACCINE; CHIMERIVAX; DENGUE VACCINE; DENGUE VIRUS ANTIBODY; FC RECEPTOR; INACTIVATED VIRUS VACCINE; LIVE VACCINE; NONSTRUCTURAL PROTEIN 1; PROTEIN E; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS PROTEIN;

EID: 79953035293     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-031210-101315     Document Type: Article
Times cited : (374)

References (209)
  • 2
    • 77950407988 scopus 로고    scopus 로고
    • Serotype-specific differences in the risk of dengue hemorrhagic fever: An analysis of data collected in Bangkok, Thailand from 1994 to 2006
    • Fried JR, Gibbons RV, Kalayanarooj S, Thomas SJ, Srikiatkhachorn A, et al. 2010. Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl. Trop. Dis. 4:e617 .
    • (2010) PLoS Negl. Trop. Dis. , vol.4
    • Fried, J.R.1    Gibbons, R.V.2    Kalayanarooj, S.3    Thomas, S.J.4    Srikiatkhachorn, A.5
  • 5
    • 0033258362 scopus 로고    scopus 로고
    • Impact of dengue/dengue hemorrhagic fever on the developing world
    • Gubler DJ, Meltzer M. 1999. Impact of dengue/dengue hemorrhagic fever on the developing world. Adv. Virus Res. 53:35-70 .
    • (1999) Adv. Virus Res. , vol.53 , pp. 35-70
    • Gubler, D.J.1    Meltzer, M.2
  • 8
    • 1442284343 scopus 로고    scopus 로고
    • Dengue epidemiology: Virus epidemiology, ecology, and emergence
    • DOI 10.1016/S0065-3527(03)61006-7, PII S0065352703610067
    • Thomas SJ, Strickman D, Vaughn DW. 2003. Dengue epidemiology: virus epidemiology, ecology, and emergence. Adv. Virus Res. 61:235-89 . (Pubitemid 137639388)
    • (2003) Advances in Virus Research , vol.61 , pp. 235-289
    • Thomas, S.J.1    Strickman, D.2    Vaughn, D.W.3
  • 9
    • 10944252079 scopus 로고    scopus 로고
    • Emerging flaviviruses: The spread and resurgence of Japanese encephalitis, West Nile and dengue viruses
    • Mackenzie JS, Gubler DJ, Petersen LR. 2004. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10:S98-109 .
    • (2004) Nat. Med. , vol.10
    • MacKenzie, J.S.1    Gubler, D.J.2    Petersen, L.R.3
  • 10
    • 50849098592 scopus 로고    scopus 로고
    • Global spread and persistence of dengue
    • Kyle JL, Harris E. 2008. Global spread and persistence of dengue. Annu. Rev. Microbiol. 62:71-92 .
    • (2008) Annu. Rev. Microbiol. , vol.62 , pp. 71-92
    • Kyle, J.L.1    Harris, E.2
  • 11
    • 63349107918 scopus 로고    scopus 로고
    • Dengue in Southeast Asia: Epidemiological characteristics and strategic challenges in disease prevention
    • Ooi EE, Gubler DJ. 2009. Dengue in Southeast Asia: epidemiological characteristics and strategic challenges in disease prevention. Cad Saude Publica 25(Suppl. 1):S115-24 .
    • (2009) Cad Saude Publica , vol.25 , Issue.SUPPL. 1
    • Ooi, E.E.1    Gubler, D.J.2
  • 12
    • 55049084757 scopus 로고    scopus 로고
    • Geographic expansion of dengue: The impact of international travel
    • Wilder-Smith A, Gubler DJ. 2008. Geographic expansion of dengue: the impact of international travel. Med. Clin. North Am. 92:1377-90 .
    • (2008) Med. Clin. North Am. , vol.92 , pp. 1377-90
    • Wilder-Smith, A.1    Gubler, D.J.2
  • 15
    • 0031823546 scopus 로고    scopus 로고
    • Dengue and dengue hemorrhagic fever
    • Gubler DJ. 1998. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 11:480-96 . (Pubitemid 28379096)
    • (1998) Clinical Microbiology Reviews , vol.11 , Issue.3 , pp. 480-496
    • Gubler, D.J.1
  • 16
    • 0037223896 scopus 로고    scopus 로고
    • A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3′ untranslated region is highly attenuated and immunogenic in monkeys
    • DOI 10.1128/JVI.77.2.1653-1657.2003
    • Whitehead SS, Falgout B, Hanley KA, Blaney JE Jr, Markoff L, Murphy BR. 2003. A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3 untranslated region is highly attenuated and immunogenic in monkeys. J. Virol. 77:1653-57 . (Pubitemid 36055591)
    • (2003) Journal of Virology , vol.77 , Issue.2 , pp. 1653-1657
    • Whitehead, S.S.1    Falgout, B.2    Hanley, K.A.3    Blaney Jr., J.E.4    Markoff, L.5    Murphy, B.R.6
  • 18
    • 10144249661 scopus 로고    scopus 로고
    • Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2
    • Blaney JE Jr, Hanson CT, Hanley KA, Murphy BR, Whitehead SS. 2004. Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2. BMC Infect. Dis. 4:39 .
    • (2004) BMC Infect. Dis. , vol.4 , pp. 39
    • Blaney Jr., J.E.1    Hanson, C.T.2    Hanley, K.A.3    Murphy, B.R.4    Whitehead, S.S.5
  • 21
    • 41349108036 scopus 로고    scopus 로고
    • Sylvatic dengue virus type 2 activity in humans, Nigeria, 1966
    • Vasilakis N, Tesh RB, Weaver SC. 2008. Sylvatic dengue virus type 2 activity in humans, Nigeria, 1966. Emerg. Infect. Dis. 14:502-4 . (Pubitemid 351451406)
    • (2008) Emerging Infectious Diseases , vol.14 , Issue.3 , pp. 502-504
    • Vasilakis, N.1    Tesh, R.B.2    Weaver, S.C.3
  • 22
    • 65549125454 scopus 로고    scopus 로고
    • Dengue virus serotype 2 from a sylvatic lineage isolated from a patient with dengue hemorrhagic fever
    • Cardosa J, Ooi MH, Tio PH, Perera D, Holmes EC, et al. 2009. Dengue virus serotype 2 from a sylvatic lineage isolated from a patient with dengue hemorrhagic fever. PLoS Negl. Trop. Dis. 3:e423 .
    • (2009) PLoS Negl. Trop. Dis. , vol.3
    • Cardosa, J.1    Ooi, M.H.2    Tio, P.H.3    Perera, D.4    Holmes, E.C.5
  • 24
    • 0030886723 scopus 로고    scopus 로고
    • Molecular evolution and phylogeny of dengue-4 viruses
    • Lanciotti RS, Gubler DJ, Trent DW. 1997. Molecular evolution and phylogeny of dengue-4 viruses. J. Gen. Virol. 78(Pt. 9):2279-84 .
    • (1997) J. Gen. Virol. , vol.78 , Issue.PART 9 , pp. 2279-84
    • Lanciotti, R.S.1    Gubler, D.J.2    Trent, D.W.3
  • 27
    • 0024340421 scopus 로고
    • Genetic relatedness among structural protein genes of dengue 1 virus strains
    • ChuMC, O'Rourke EJ, Trent DW. 1989. Genetic relatedness among structural protein genes of dengue 1 virus strains. J. Gen. Virol. 70(Pt. 7):1701-12 . (Pubitemid 19170207)
    • (1989) Journal of General Virology , vol.70 , Issue.7 , pp. 1701-1712
    • Chu, M.C.1    O'Rourke, E.J.2    Trent, D.W.3
  • 28
    • 77950240665 scopus 로고    scopus 로고
    • Dengue hemorrhagic fever: The sensitivity and specificity of the World Health Organization definition for identification of severe cases of dengue in Thailand 1994-2005
    • Srikiatkhachorn A, Gibbons RV, Green S, Libraty DH, Thomas SJ, et al. 2010. Dengue hemorrhagic fever: the sensitivity and specificity of the World Health Organization definition for identification of severe cases of dengue in Thailand, 1994-2005. Clin. Infect. Dis. 50:1135-43 .
    • (2010) Clin. Infect. Dis. , vol.50 , pp. 1135-43
    • Srikiatkhachorn, A.1    Gibbons, R.V.2    Green, S.3    Libraty, D.H.4    Thomas, S.J.5
  • 31
    • 0002128020 scopus 로고
    • An account of the bilious remitting fever, as it appeared in Philadelphia, in the summer and autumn of the year 1780
    • Philadelphia: Prichard and Hall
    • Rush B. 1789. An account of the bilious remitting fever, as it appeared in Philadelphia, in the summer and autumn of the year 1780. In Medical Inquiries and Observations, pp. 89-100. Philadelphia: Prichard and Hall .
    • (1789) Medical Inquiries and Observations , pp. 89-100
    • Rush, B.1
  • 32
    • 0000891046 scopus 로고
    • TheThai hemorrhagic fever epidemic of 1962: A preliminary report
    • Halstead SB, Yamarat C, Scanlon JE. 1963. TheThai hemorrhagic fever epidemic of 1962: a preliminary report. J. Med. Assoc. Thai. 46:449-62 .
    • (1963) J. Med. Assoc. Thai. , vol.46 , pp. 449-62
    • Halstead, S.B.1    Yamarat, C.2    Scanlon, J.E.3
  • 33
    • 74049086608 scopus 로고    scopus 로고
    • Prospective cohort studies of dengue viral transmission and severity of disease
    • Endy TP, Yoon IK, Mammen MP. 2010. Prospective cohort studies of dengue viral transmission and severity of disease. Curr. Top. Microbiol. Immunol. 338:1-13 .
    • (2010) Curr. Top. Microbiol. Immunol. , vol.338 , pp. 1-13
    • Endy, T.P.1    Yoon, I.K.2    Mammen, M.P.3
  • 34
    • 71949112681 scopus 로고    scopus 로고
    • Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua
    • Balmaseda A, Standish K, Mercado JC, Matute JC, Tellez Y, et al. 2010. Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua. J. Infect. Dis. 201:5-14 .
    • (2010) J. Infect. Dis. , vol.201 , pp. 5-14
    • Balmaseda, A.1    Standish, K.2    Mercado, J.C.3    Matute, J.C.4    Tellez, Y.5
  • 35
    • 76949113583 scopus 로고
    • Research on dengue during World War II
    • Sabin AB. 1952. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1:30-50 .
    • (1952) Am. J. Trop. Med. Hyg. , vol.1 , pp. 30-50
    • Sabin, A.B.1
  • 36
    • 0002084874 scopus 로고
    • Dengue: Its history, epidemiology, mechanism of transmission, etiology, clinical manifestations, immunity, and prevention
    • Siler JF, Hall MW, Hitchens AP. 1926. Dengue: its history, epidemiology, mechanism of transmission, etiology, clinical manifestations, immunity, and prevention. Philipp. J. Sci. 29:1-304 .
    • (1926) Philipp. J. Sci. , vol.29 , pp. 1-304
    • Siler, J.F.1    Hall, M.W.2    Hitchens, A.P.3
  • 38
  • 39
    • 0014602625 scopus 로고
    • Dengue and Chikungunya virus infection in man in Thailand 1962-1964: II. Observations on disease in outpatients
    • Halstead SB, Nimmannitya S, Margiotta MR. 1969. Dengue and Chikungunya virus infection in man in Thailand, 1962-1964: II. Observations on disease in outpatients. Am. J. Trop. Med. Hyg. 18:972-83 .
    • (1969) Am. J. Trop. Med. Hyg. , vol.18 , pp. 972-83
    • Halstead, S.B.1    Nimmannitya, S.2    Margiotta, M.R.3
  • 40
    • 0033915304 scopus 로고    scopus 로고
    • Dengue virus and dendritic cells
    • DOI 10.1038/77470
    • Palucka AK. 2000. Dengue virus and dendritic cells. Nat. Med. 6:748-49 . (Pubitemid 30469416)
    • (2000) Nature Medicine , vol.6 , Issue.7 , pp. 748-749
    • Palucka, A.K.1
  • 42
    • 36849074407 scopus 로고    scopus 로고
    • Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells
    • DOI 10.1002/jmv.21051
    • Kou Z, Quinn M, Chen H, Rodrigo WW, Rose RC, et al. 2008. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. J. Med. Virol. 80:134-46 . (Pubitemid 350220099)
    • (2008) Journal of Medical Virology , vol.80 , Issue.1 , pp. 134-146
    • Kou, Z.1    Quinn, M.2    Chen, H.3    Rodrigo, W.W.S.I.4    Rose, R.C.5    Schlesinger, J.J.6    Jin, X.7
  • 43
    • 37049009945 scopus 로고    scopus 로고
    • Primary Human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro
    • DOI 10.1128/JVI.01568-07
    • Blackley S, Kou Z, Chen H, Quinn M, Rose RC, et al. 2007. Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. J. Virol. 81:13325-34 . (Pubitemid 350247829)
    • (2007) Journal of Virology , vol.81 , Issue.24 , pp. 13325-13334
    • Blackley, S.1    Kou, Z.2    Chen, H.3    Quinn, M.4    Rose, R.C.5    Schlesinger, J.J.6    Coppage, M.7    Jin, X.8
  • 44
    • 2142806767 scopus 로고    scopus 로고
    • Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization
    • DOI 10.1086/383043
    • Jessie K, FongMY, Devi S, Lam SK, Wong KT. 2004. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J. Infect. Dis. 189:1411-18 . (Pubitemid 38543590)
    • (2004) Journal of Infectious Diseases , vol.189 , Issue.8 , pp. 1411-1418
    • Jessie, K.1    Fong, M.Y.2    Devi, S.3    Lam, S.K.4    Wong, K.T.5
  • 46
  • 47
    • 0014600226 scopus 로고
    • Dengue and Chikungunya virus infection in man in Thailand 1962-1964: IV. Epidemiologic studies in the Bangkok metropolitan area
    • Halstead SB, Scanlon J, Umpaivit P, Udomsakdi S. 1969. Dengue and Chikungunya virus infection in man in Thailand, 1962-1964: IV. Epidemiologic studies in the Bangkok metropolitan area. Am. J. Trop. Med. Hyg. 18:997-1021 .
    • (1969) Am. J. Trop. Med. Hyg. , vol.18 , pp. 997-1021
    • Halstead, S.B.1    Scanlon, J.2    Umpaivit, P.3    Udomsakdi, S.4
  • 48
    • 0001955284 scopus 로고
    • Dengue and dengue hemorrhagic fever
    • ed. JS Porterfield London Chapman & Hall Med.
    • Innis BL. 1995. Dengue and dengue hemorrhagic fever. In Kass Handbook of Infectious Diseases: Exotic Virus Infections, ed. JS Porterfield, pp. 103-46. London: Chapman & Hall Med. .
    • (1995) Kass Handbook of Infectious Diseases: Exotic Virus Infections , pp. 103-46
    • Innis, B.L.1
  • 49
    • 0346887223 scopus 로고    scopus 로고
    • Clinical presentations of dengue hemorrhagic fever in infants compared to children
    • Kalayanarooj S, Nimmannitya S. 2003. Clinical presentations of dengue hemorrhagic fever in infants compared to children. J. Med. Assoc. Thai. 86(Suppl. 3):S673-80 . (Pubitemid 38009759)
    • (2003) Journal of the Medical Association of Thailand , vol.86 , Issue.SUPPL. 3
    • Kalayanarooj, S.1    Nimmannitya, S.2
  • 50
    • 16644401688 scopus 로고    scopus 로고
    • Aminotransferase changes and acute hepatitis in patients with dengue fever: Analysis of 1, 585 cases
    • Souza LJ, Alves JG, Nogueira RM, Gicovate Neto C, Bastos DA, et al. 2004. Aminotransferase changes and acute hepatitis in patients with dengue fever: analysis of 1, 585 cases. Braz. J. Infect. Dis. 8:156-63 .
    • (2004) Braz. J. Infect. Dis. , vol.8 , pp. 156-63
    • Souza, L.J.1    Alves, J.G.2    Nogueira, R.M.3    Gicovate Neto, C.4    Bastos, D.A.5
  • 52
    • 24944474825 scopus 로고    scopus 로고
    • Epidemiology, clinical features, laboratory investigations and early diagnosis of dengue fever in adults: A descriptive study in Sri Lanka
    • Kularatne SA, Gawarammana IB, Kumarasiri PR. 2005. Epidemiology, clinical features, laboratory investigations and early diagnosis of dengue fever in adults: a descriptive study in Sri Lanka. Southeast Asian J. Trop. Med. Public Health 36:686-92 . (Pubitemid 41316795)
    • (2005) Southeast Asian Journal of Tropical Medicine and Public Health , vol.36 , Issue.3 , pp. 686-692
    • Kularatne, S.A.M.1    Gawarammana, I.B.2    Kumarasiri, P.R.V.3
  • 53
    • 70449717376 scopus 로고    scopus 로고
    • Phase 1 trial of the dengue virus type 4 vaccine candidate rDEN4-30-4995 in healthy adult volunteers
    • Wright PF, Durbin AP, Whitehead SS, IkizlerMR, Henderson S, et al. 2009. Phase 1 trial of the dengue virus type 4 vaccine candidate rDEN4-30-4995 in healthy adult volunteers. Am. J. Trop. Med. Hyg. 81:834-41 .
    • (2009) Am. J. Trop. Med. Hyg. , vol.81 , pp. 834-41
    • Wright, P.F.1    Durbin, A.P.2    Whitehead, S.S.3    Ikizler, M.R.4    Henderson, S.5
  • 54
    • 55849093621 scopus 로고    scopus 로고
    • Phase i clinical evaluation of rDEN4 30-200 201: A live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity
    • McArthur JH, DurbinAP, Marron JA, Wanionek KA, Thumar B, et al. 2008. Phase I clinical evaluation of rDEN4-30-200, 201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity. Am. J. Trop. Med. Hyg. 79:678-84 .
    • (2008) Am. J. Trop. Med. Hyg. , vol.79 , pp. 678-84
    • McArthur, J.H.1    Durbin, A.P.2    Marron, J.A.3    Wanionek, K.A.4    Thumar, B.5
  • 55
    • 33845895530 scopus 로고    scopus 로고
    • Rden2/4-30(ME), a live attenuated chimeric dengue serotype 2 vaccine is safe and highly immunogenic in healthy dengue-naive adults
    • Durbin AP, McArthur JH, Marron JA, Blaney JE, Thumar B, et al. 2006. rDEN2/4-30(ME), a live attenuated chimeric dengue serotype 2 vaccine is safe and highly immunogenic in healthy dengue-naive adults. Hum. Vaccin. 2:255-60 .
    • (2006) Hum. Vaccin. , vol.2 , pp. 255-60
    • Durbin, A.P.1    McArthur, J.H.2    Marron, J.A.3    Blaney, J.E.4    Thumar, B.5
  • 59
    • 0023403265 scopus 로고
    • Clinical spectrum andmanagement of dengue haemorrhagic fever
    • Nimmannitya S. 1987. Clinical spectrum andmanagement of dengue haemorrhagic fever. Southeast Asian J. Trop. Med. Public Health 18:392-97 .
    • (1987) Southeast Asian J. Trop. Med. Public Health , vol.18 , pp. 392-97
    • Nimmannitya, S.1
  • 60
    • 0034003808 scopus 로고    scopus 로고
    • Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia
    • DOI 10.1002/(SICI)1096-9071(200004)60:4<432::AID-JMV11>3.0.CO;2-7
    • Murgue B, Roche C, Chungue E, Deparis X. 2000. Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia. J. Med. Virol. 60:432-38 . (Pubitemid 30127315)
    • (2000) Journal of Medical Virology , vol.60 , Issue.4 , pp. 432-438
    • Murgue, B.1    Roche, C.2    Chungue, E.3    Deparis, X.4
  • 61
    • 0026025910 scopus 로고
    • Ultrasound findings in dengue haemorrhagic fever
    • Pramulijo HS, Harun SR. 1991. Ultrasound findings in dengue haemorrhagic fever. Pediatr. Radiol. 21:100-2 .
    • (1991) Pediatr. Radiol. , vol.21 , pp. 100-2
    • Pramulijo, H.S.1    Harun, S.R.2
  • 63
    • 39149085372 scopus 로고    scopus 로고
    • Management of severe dengue in Children
    • Moxon C, Wills B. 2008. Management of severe dengue in Children. Adv. Exp. Med. Biol. 609:131-44 .
    • (2008) Adv. Exp. Med. Biol. , vol.609 , pp. 131-44
    • Moxon, C.1    Wills, B.2
  • 64
    • 68549136597 scopus 로고    scopus 로고
    • Improvement in hospital indicators after changes in dengue case management in Nicaragua
    • Rocha C, Silva S, Gordon A, Hammond SN, Elizondo D, et al. 2009. Improvement in hospital indicators after changes in dengue case management in Nicaragua. Am. J. Trop. Med. Hyg. 81:287-92 .
    • (2009) Am. J. Trop. Med. Hyg. , vol.81 , pp. 287-92
    • Rocha, C.1    Silva, S.2    Gordon, A.3    Hammond, S.N.4    Elizondo, D.5
  • 65
    • 20844441280 scopus 로고    scopus 로고
    • Dengue hemorrhagic fever and fulminant hepatic failure
    • DOI 10.1007/s10620-005-2722-6
    • Subramanian V, Shenoy S, Joseph AJ. 2005. Dengue hemorrhagic fever and fulminant hepatic failure. Dig. Dis. Sci. 50:1146-47 . (Pubitemid 40864025)
    • (2005) Digestive Diseases and Sciences , vol.50 , Issue.6 , pp. 1146-1147
    • Subramanian, V.1    Shenoy, S.2    Joseph, A.J.3
  • 69
    • 4644239393 scopus 로고    scopus 로고
    • Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand
    • DOI 10.1111/j.1365-3156.2004.01295.x
    • Wichmann O, Hongsiriwon S, Bowonwatanuwong C, Chotivanich K, Sukthana Y, Pukrittayakamee S. 2004. Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand. Trop. Med. Int. Health 9:1022-29 . (Pubitemid 39279005)
    • (2004) Tropical Medicine and International Health , vol.9 , Issue.9 , pp. 1022-1029
    • Wichmann, O.1    Hongsiriwon, S.2    Bowonwatanuwong, C.3    Chotivanich, K.4    Sukthana, Y.5    Pukrittayakamee, S.6
  • 70
    • 70350445041 scopus 로고    scopus 로고
    • T lymphocyte responses to heterologous secondary dengue virus infections
    • Rothman AL. 2009. T lymphocyte responses to heterologous secondary dengue virus infections. Ann. N. Y. Acad. Sci. 1171(Suppl. 1):E36-41 .
    • (2009) Ann. N. Y. Acad. Sci. , vol.1171 , Issue.SUPPL. 1
    • Rothman, A.L.1
  • 71
    • 2142827156 scopus 로고    scopus 로고
    • Dengue: Defining protective versus pathologic immunity
    • DOI 10.1172/JCI200421512
    • Rothman AL. 2004. Dengue: defining protective versus pathologic immunity. J. Clin. Investig. 113:946-51 . (Pubitemid 38544112)
    • (2004) Journal of Clinical Investigation , vol.113 , Issue.7 , pp. 946-951
    • Rothman, A.L.1
  • 73
    • 34247374654 scopus 로고    scopus 로고
    • The burden of dengue infection
    • DOI 10.1016/S0140-6736(07)60645-X, PII S014067360760645X
    • Halstead SB, Suaya JA, Shepard DS. 2007. The burden of dengue infection. Lancet 369:1410-11 . (Pubitemid 46635764)
    • (2007) Lancet , vol.369 , Issue.9571 , pp. 1410-1411
    • Halstead, S.B.1    Suaya, J.A.2    Shepard, D.S.3
  • 75
    • 74049107391 scopus 로고    scopus 로고
    • HLA and other gene associations with dengue disease severity
    • Stephens HA. 2010. HLA and other gene associations with dengue disease severity. Curr. Top. Microbiol. Immunol. 338:99-114 .
    • (2010) Curr. Top. Microbiol. Immunol. , vol.338 , pp. 99-114
    • Stephens, H.A.1
  • 78
    • 33144458778 scopus 로고    scopus 로고
    • RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication
    • DOI 10.1128/JVI.80.5.2170-2182.2006
    • Clyde K, Harris E. 2006. RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication. J. Virol. 80:2170-82 . (Pubitemid 43271524)
    • (2006) Journal of Virology , vol.80 , Issue.5 , pp. 2170-2182
    • Clyde, K.1    Harris, E.2
  • 79
    • 11144244755 scopus 로고    scopus 로고
    • Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein
    • DOI 10.1128/JVI.79.2.1223-1231.2005
    • Modis Y, Ogata S, Clements D, Harrison SC. 2005. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J. Virol. 79:1223-31 . (Pubitemid 40053904)
    • (2005) Journal of Virology , vol.79 , Issue.2 , pp. 1223-1231
    • Modis, Y.1    Ogata, S.2    Clements, D.3    Harrison, S.C.4
  • 80
    • 11144348130 scopus 로고    scopus 로고
    • A structural perspective of the Flavivirus life cycle
    • DOI 10.1038/nrmicro1067
    • Mukhopadhyay S, Kuhn RJ, Rossmann MG. 2005. A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 3:13-22 . (Pubitemid 40028466)
    • (2005) Nature Reviews Microbiology , vol.3 , Issue.1 , pp. 13-22
    • Mukhopadhyay, S.1    Kuhn, R.J.2    Rossmann, M.G.3
  • 84
    • 0035051804 scopus 로고    scopus 로고
    • Mutational evidence for an internal fusion peptide in flavivirus envelope protein E
    • DOI 10.1128/JVI.75.9.4268-4275.2001
    • Allison SL, Schalich J, Stiasny K, Mandl CW, Heinz FX. 2001. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J. Virol. 75:4268-75 . (Pubitemid 32410139)
    • (2001) Journal of Virology , vol.75 , Issue.9 , pp. 4268-4275
    • Allison, S.L.1    Schalich, J.2    Stiasny, K.3    Mandl, C.W.4    Heinz, F.X.5
  • 85
    • 1642499388 scopus 로고    scopus 로고
    • Structure of the dengue virus envelope protein after membrane fusion
    • DOI 10.1038/nature02165
    • Modis Y, Ogata S, Clements D, Harrison SC. 2004. Structure of the dengue virus envelope protein after membrane fusion. Nature 427:313-19 . (Pubitemid 38133652)
    • (2004) Nature , vol.427 , Issue.6972 , pp. 313-319
    • Modis, Y.1    Ogata, S.2    Clements, D.3    Harrison, S.C.4
  • 86
    • 0029014434 scopus 로고
    • The envelope glycoprotein from tick-borne encephalitis virus at 2 angstrom resolution
    • Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC. 1995. The envelope glycoprotein from tick-borne encephalitis virus at 2 angstrom resolution. Nature 375:291-98 .
    • (1995) Nature , vol.375 , pp. 291-98
    • Rey, F.A.1    Heinz, F.X.2    Mandl, C.3    Kunz, C.4    Harrison, S.C.5
  • 87
    • 69249213373 scopus 로고    scopus 로고
    • Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
    • WahalaWM, Kraus AA, HaymoreLB, Accavitti-LoperMA, de Silva AM. 2009. Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. Virology 392:103-13 .
    • (2009) Virology , vol.392 , pp. 103-13
    • Wahala, W.M.1    Kraus, A.A.2    Haymore, L.B.3    Accavitti-Loper, M.A.4    De Silva, A.M.5
  • 88
    • 0022450456 scopus 로고
    • A new mechanism for the neutralization of enveloped viruses by antiviral antibody
    • Gollins SW, Porterfield JS. 1986. A new mechanism for the neutralization of enveloped viruses by antiviral antibody. Nature 321:244-46 . (Pubitemid 16016417)
    • (1986) Nature , vol.321 , Issue.6067 , pp. 244-246
    • Gollins, S.W.1    Porterfield, J.S.2
  • 89
    • 26944454471 scopus 로고    scopus 로고
    • Structural basis of West Nile virus neutralization by a therapeutic antibody
    • DOI 10.1038/nature03956, PII N03956
    • Nybakken GE, Oliphant T, Johnson S, Burke S, Diamond MS, Fremont DH. 2005. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437:764-69 . (Pubitemid 41486548)
    • (2005) Nature , vol.437 , Issue.7059 , pp. 764-769
    • Nybakken, G.E.1    Oliphant, T.2    Johnson, S.3    Burke, S.4    Diamond, M.S.5    Fremont, D.H.6
  • 93
    • 64249106079 scopus 로고    scopus 로고
    • Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens
    • Crill WD, Hughes HR, Delorey MJ, Chang GJ. 2009. Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens. PLoS ONE 4:e4991 .
    • (2009) PLoS ONE , vol.4
    • Crill, W.D.1    Hughes, H.R.2    Delorey, M.J.3    Chang, G.J.4
  • 94
    • 53249134451 scopus 로고    scopus 로고
    • Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model
    • Kyle JL, Balsitis SJ, Zhang L, Beatty PR, Harris E. 2008. Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model. Virology 380:296-303 .
    • (2008) Virology , vol.380 , pp. 296-303
    • Kyle, J.L.1    Balsitis, S.J.2    Zhang, L.3    Beatty, P.R.4    Harris, E.5
  • 95
    • 1642415963 scopus 로고    scopus 로고
    • Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand
    • DOI 10.1086/382280
    • Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, et al. 2004. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J. Infect. Dis. 189:990-1000 . (Pubitemid 38373090)
    • (2004) Journal of Infectious Diseases , vol.189 , Issue.6 , pp. 990-1000
    • Endy, T.P.1    Nisalak, A.2    Chunsuttitwat, S.3    Vaughn, D.W.4    Green, S.5    Ennis, F.A.6    Rothman, A.L.7    Libraty, D.H.8
  • 96
    • 70350452043 scopus 로고    scopus 로고
    • Antibodies determine virulence in dengue
    • Halstead SB. 2009. Antibodies determine virulence in dengue. Ann. N. Y. Acad. Sci. 1171(Suppl. 1):E48- 56 .
    • (2009) Ann. N. Y. Acad. Sci. , vol.1171 , Issue.SUPPL. 1
    • Halstead, S.B.1
  • 99
    • 45749131789 scopus 로고    scopus 로고
    • Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II
    • Lai CY, Tsai WY, Lin SR, Kao CL, Hu HP, et al. 2008. Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J. Virol. 82:6631-43 .
    • (2008) J. Virol. , vol.82 , pp. 6631-43
    • Lai, C.Y.1    Tsai, W.Y.2    Lin, S.R.3    Kao, C.L.4    Hu, H.P.5
  • 100
    • 77956605864 scopus 로고    scopus 로고
    • The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity
    • Beltramello M, Williams KL, Simmons CP, Macagno A, Simonelli L, et al. 2010. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 8(3):271-83 .
    • (2010) Cell Host Microbe , vol.8 , Issue.3 , pp. 271-83
    • Beltramello, M.1    Williams, K.L.2    Simmons, C.P.3    MacAgno, A.4    Simonelli, L.5
  • 101
    • 0021702322 scopus 로고
    • Risk factors in dengue shock syndrome: A prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak
    • Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, et al. 1984. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 120:653-69 . (Pubitemid 15210730)
    • (1984) American Journal of Epidemiology , vol.120 , Issue.5 , pp. 653-669
    • Sangkawibha, N.1    Rojanasuphot, S.2    Ahandrik, S.3
  • 103
    • 0023864994 scopus 로고
    • Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants
    • Kliks SC, Nimmannitya S, Nisalak A, Burke DS. 1988. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am. J. Trop. Med. Hyg. 38:411-19 . (Pubitemid 18086128)
    • (1988) American Journal of Tropical Medicine and Hygiene , vol.38 , Issue.2 , pp. 411-419
    • Kliks, S.C.1    Nimmanitya, S.2    Nisalak, A.3    Burke, D.S.4
  • 105
    • 71949129268 scopus 로고    scopus 로고
    • Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants
    • Chau TN, HieuNT, Anders KL, Wolbers M, Lien le B, et al. 2009. Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants. J. Infect. Dis. 200:1893-900 .
    • (2009) J. Infect. Dis. , vol.200 , pp. 1893-900
    • Chau, T.N.1    Hieu, N.T.2    Anders, K.L.3    Wolbers, M.4    Lien Le, B.5
  • 106
    • 70449122704 scopus 로고    scopus 로고
    • A prospective nested case-control study of dengue in infants: Rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model
    • Libraty DH, Acosta LP, Tallo V, Segubre-Mercado E, Bautista A, et al. 2009. A prospective nested case-control study of dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model. PLoS Med. 6:e1000171 .
    • (2009) PLoS Med. , vol.6
    • Libraty, D.H.1    Acosta, L.P.2    Tallo, V.3    Segubre-Mercado, E.4    Bautista, A.5
  • 108
    • 17444413399 scopus 로고    scopus 로고
    • Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys
    • DOI 10.1128/JVI.79.9.5516-5528.2005
    • Blaney JE Jr, Matro JM, Murphy BR, Whitehead SS. 2005. Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys. J. Virol. 79:5516-28 . (Pubitemid 40548220)
    • (2005) Journal of Virology , vol.79 , Issue.9 , pp. 5516-5528
    • Blaney Jr., J.E.1    Matro, J.M.2    Murphy, B.R.3    Whitehead, S.S.4
  • 109
    • 1342267637 scopus 로고    scopus 로고
    • Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates
    • Sun W, Edelman R, Kanesa-Thasan N, Eckels KH, Putnak JR, et al. 2003. Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates. Am. J. Trop. Med. Hyg. 69:24-31 .
    • (2003) Am. J. Trop. Med. Hyg. , vol.69 , pp. 24-31
    • Sun, W.1    Edelman, R.2    Kanesa-Thasan, N.3    Eckels, K.H.4    Putnak, J.R.5
  • 111
    • 70749109995 scopus 로고    scopus 로고
    • Protection against dengue virus by nonreplicating and live attenuated vaccines used together in a prime boost vaccination strategy
    • Simmons M, Burgess T, Lynch J, Putnak R. 2010. Protection against dengue virus by nonreplicating and live attenuated vaccines used together in a prime boost vaccination strategy. Virology 396:280-88 .
    • (2010) Virology , vol.396 , pp. 280-88
    • Simmons, M.1    Burgess, T.2    Lynch, J.3    Putnak, R.4
  • 112
    • 56549118853 scopus 로고    scopus 로고
    • Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection
    • Pierson TC, Diamond MS. 2008. Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection. Expert Rev. Mol. Med. 10:e12 .
    • (2008) Expert Rev. Mol. Med. , vol.10
    • Pierson, T.C.1    Diamond, M.S.2
  • 113
    • 70449095877 scopus 로고    scopus 로고
    • Dengue virus neutralization is modulated by IgG antibody subclass and Fcγreceptor subtype
    • Rodrigo WW, Block OK, Lane C, Sukupolvi-Petty S, Goncalvez AP, et al. 2009. Dengue virus neutralization is modulated by IgG antibody subclass and Fcγreceptor subtype. Virology 394:175-82 .
    • (2009) Virology , vol.394 , pp. 175-82
    • Rodrigo, W.W.1    Block, O.K.2    Lane, C.3    Sukupolvi-Petty, S.4    Goncalvez, A.P.5
  • 114
    • 50849120046 scopus 로고    scopus 로고
    • Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: Implications for vaccine development
    • Pierson TC, Fremont DH, Kuhn RJ, DiamondMS. 2008. Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe 4:229-38 .
    • (2008) Cell Host Microbe , vol.4 , pp. 229-38
    • Pierson, T.C.1    Fremont, D.H.2    Kuhn, R.J.3    Diamond, M.S.4
  • 115
    • 72649088588 scopus 로고    scopus 로고
    • Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization ofWest Nile virus
    • Mehlhop E, Nelson S, Jost CA, Gorlatov S, Johnson S, et al. 2009. Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization ofWest Nile virus. Cell Host Microbe 6:381-91 .
    • (2009) Cell Host Microbe , vol.6 , pp. 381-91
    • Mehlhop, E.1    Nelson, S.2    Jost, C.A.3    Gorlatov, S.4    Johnson, S.5
  • 117
    • 44449143037 scopus 로고    scopus 로고
    • Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization
    • Nelson S, Jost CA, Xu Q, Ess J, Martin JE, et al. 2008. Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization. PLoS Pathog. 4:e1000060 .
    • (2008) PLoS Pathog. , vol.4
    • Nelson, S.1    Jost, C.A.2    Xu, Q.3    Ess, J.4    Martin, J.E.5
  • 118
    • 79953051949 scopus 로고    scopus 로고
    • Progress in passive immunotherapy
    • ed. KA Hanley, SCWeaver Norfolk: Caister Acad. Press
    • Goncalvez AP, Purcell RH, Lai CJ. 2010. Progress in passive immunotherapy. In Frontiers in Dengue Virus Research, ed. KA Hanley, SCWeaver, pp. 265-97. Norfolk: Caister Acad. Press .
    • (2010) Frontiers in Dengue Virus Research , pp. 265-97
    • Goncalvez, A.P.1    Purcell, R.H.2    Lai, C.J.3
  • 122
    • 0025308282 scopus 로고
    • Passive protection studies in mice with monoclonal antibodies directed against the non-structural protein NS3 of dengue 1 virus
    • Tan CH, Yap EH, Singh M, Deubel V, Chan YC. 1990. Passive protection studies in mice with monoclonal antibodies directed against the nonstructural protein NS3 of dengue 1 virus. J. Gen. Virol. 71:745-49 . (Pubitemid 20111924)
    • (1990) Journal of General Virology , vol.71 , Issue.3 , pp. 745-749
    • Tan, C.H.-C.1    Yap -., E.H.2    Singh, M.3    Deubel, V.4    Chan, Y.-C.5
  • 123
    • 0023784098 scopus 로고
    • Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus
    • Henchal EA, Henchal LS, Schlesinger JJ. 1988. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. J. Gen. Virol. 69:2101-7 .
    • (1988) J. Gen. Virol. , vol.69 , pp. 2101-7
    • Henchal, E.A.1    Henchal, L.S.2    Schlesinger, J.J.3
  • 124
    • 52049102222 scopus 로고    scopus 로고
    • Understanding the contribution of cellular immunity to dengue disease pathogenesis
    • Mathew A, Rothman AL. 2008. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol. Rev. 225:300-13 .
    • (2008) Immunol. Rev. , vol.225 , pp. 300-13
    • Mathew, A.1    Rothman, A.L.2
  • 129
    • 70350445041 scopus 로고    scopus 로고
    • T lymphocyte responses to heterologous secondary dengue virus infections
    • Rothman AL. 2009. T lymphocyte responses to heterologous secondary dengue virus infections. Ann. N. Y. Acad. Sci. 1171(Suppl. 1):E36-41 .
    • (2009) Ann. N. Y. Acad. Sci. , vol.1171 , Issue.SUPPL. 1
    • Rothman, A.L.1
  • 131
    • 60149094510 scopus 로고    scopus 로고
    • The cellular immune response plays an important role in protecting against dengue virus in the mouse encephalitis model
    • Gil L, Lopez C, Blanco A, Lazo L, Martin J, et al. 2009. The cellular immune response plays an important role in protecting against dengue virus in the mouse encephalitis model. Viral. Immunol. 22:23-30 .
    • (2009) Viral. Immunol. , vol.22 , pp. 23-30
    • Gil, L.1    Lopez, C.2    Blanco, A.3    Lazo, L.4    Martin, J.5
  • 132
    • 31644433605 scopus 로고    scopus 로고
    • Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challenge
    • DOI 10.1099/vir.0.81256-0
    • Calvert AE, Huang CY, Kinney RM, Roehrig JT. 2006. Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challenge. J. Gen. Virol. 87:339-46 . (Pubitemid 43169260)
    • (2006) Journal of General Virology , vol.87 , Issue.2 , pp. 339-346
    • Calvert, A.E.1    Huang, C.Y.-H.2    Kinney, R.M.3    Roehrig, J.T.4
  • 133
    • 0023464325 scopus 로고
    • Clinical and serologic study of Cuban children with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS)
    • Guzman MG, Kouri G, Martinez E, Bravo J, Riveron R, et al. 1987. Clinical and serologic study of Cuban children with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). Bull. Pan Am. Health Organ. 21:270-79 .
    • (1987) Bull. Pan Am. Health Organ. , vol.21 , pp. 270-79
    • Guzman, M.G.1    Kouri, G.2    Martinez, E.3    Bravo, J.4    Riveron, R.5
  • 134
    • 0014775305 scopus 로고
    • Observations related to pathogenesis of dengue hemorrhagic fever IV. Relation of disease severity to antibody response and virus recovered
    • Halstead SB, Nimmannitya S, Cohen SN. 1970. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J. Biol. Med. 42:311-28 .
    • (1970) Yale J. Biol. Med. , vol.42 , pp. 311-28
    • Halstead, S.B.1    Nimmannitya, S.2    Cohen, S.N.3
  • 137
    • 70449122704 scopus 로고    scopus 로고
    • A prospective nested case-control study of Dengue in infants: Rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model
    • Libraty DH, Acosta LP, Tallo V, Segubre-Mercado E, Bautista A, et al. 2009. A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model. PLoS Med. 6(10):e1000171 .
    • (2009) PLoS Med. , vol.6 , Issue.10
    • Libraty, D.H.1    Acosta, L.P.2    Tallo, V.3    Segubre-Mercado, E.4    Bautista, A.5
  • 139
    • 0018580825 scopus 로고
    • In vivo enhancement of Dengue virus infection in rhesus monkeys by passively transferred antibody
    • Halstead SB. 1979. In vivo enhancement of dengue virus infection in Rhesus monkeys by passively transferred antibody. J. Infect. Dis. 140:527-33 . (Pubitemid 10172725)
    • (1979) Journal of Infectious Diseases , vol.140 , Issue.4 , pp. 527-533
    • Halstead, S.B.1
  • 140
    • 77649262630 scopus 로고    scopus 로고
    • Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification
    • Balsitis SJ, Williams KL, Lachica R, Flores D, Kyle JL, et al. 2010. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog. 6:e1000790 .
    • (2010) PLoS Pathog. , vol.6
    • Balsitis, S.J.1    Williams, K.L.2    Lachica, R.3    Flores, D.4    Kyle, J.L.5
  • 141
    • 76249103868 scopus 로고    scopus 로고
    • Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease
    • Zellweger RM, Prestwood TR, Shresta S. 2010. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 7:128-39 .
    • (2010) Cell Host Microbe , vol.7 , pp. 128-39
    • Zellweger, R.M.1    Prestwood, T.R.2    Shresta, S.3
  • 142
    • 70350452043 scopus 로고    scopus 로고
    • Antibodies determine virulence in dengue
    • Halstead SB. 2009. Antibodies determine virulence in dengue. Ann. N. Y. Acad. Sci. 1171(Suppl. 1):E48- 56 .
    • (2009) Ann. N. Y. Acad. Sci. , vol.1171 , Issue.SUPPL. 1
    • Halstead, S.B.1
  • 143
    • 77955710423 scopus 로고    scopus 로고
    • Dengue virus life cycle: Viral and host factors modulating infectivity
    • Rodenhuis-Zybert IA, Wilschut J, Smit JM. 2010. Dengue virus life cycle: viral and host factors modulating infectivity. Cell. Mol. Life Sci. 67:2773-86 .
    • (2010) Cell. Mol. Life Sci. , vol.67 , pp. 2773-86
    • Rodenhuis-Zybert, I.A.1    Wilschut, J.2    Smit, J.M.3
  • 146
    • 74049116296 scopus 로고    scopus 로고
    • Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis
    • Rothman AL. 2010. Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis. Curr. Top. Microbiol. Immunol. 338:83-98 .
    • (2010) Curr. Top. Microbiol. Immunol. , vol.338 , pp. 83-98
    • Rothman, A.L.1
  • 147
    • 9144248265 scopus 로고    scopus 로고
    • Dengue hemorrhagic fever in infants: A study of clinical and cytokine profiles
    • Nguyen TH, Lei HY, Nguyen TL, Lin YS, Huang KJ, et al. 2004. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J. Infect. Dis. 189:221-32 .
    • (2004) J. Infect. Dis. , vol.189 , pp. 221-32
    • Nguyen, T.H.1    Lei, H.Y.2    Nguyen, T.L.3    Lin, Y.S.4    Huang, K.J.5
  • 148
    • 33748366332 scopus 로고    scopus 로고
    • Immunopathological mechanisms in dengue and dengue hemorrhagic fever
    • DOI 10.1097/01.qco.0000244047.31135.fa, PII 0000143220061000000006
    • Green S, Rothman A. 2006. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr. Opin. Infect. Dis. 19:429-36 . (Pubitemid 44338101)
    • (2006) Current Opinion in Infectious Diseases , vol.19 , Issue.5 , pp. 429-436
    • Green, S.1    Rothman, A.2
  • 149
  • 150
    • 17244375118 scopus 로고    scopus 로고
    • Understanding dengue pathogenesis: Implications for vaccine design
    • Stephenson JR. 2005. Understanding dengue pathogenesis: implications for vaccine design. Bull. World Health Organ. 83:308-14 . (Pubitemid 40529628)
    • (2005) Bulletin of the World Health Organization , vol.83 , Issue.4 , pp. 308-314
    • Stephenson, J.R.1
  • 151
    • 33645798035 scopus 로고    scopus 로고
    • Vascular leakage in severe dengue virus infections: A potential role for the nonstructural viral protein NS1 and complement
    • Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, et al. 2006. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J. Infect. Dis. 193:1078-88 .
    • (2006) J. Infect. Dis. , vol.193 , pp. 1078-88
    • Avirutnan, P.1    Punyadee, N.2    Noisakran, S.3    Komoltri, C.4    Thiemmeca, S.5
  • 152
    • 33749454503 scopus 로고    scopus 로고
    • Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human FcγRIA (CD64) or FcγRIIA (CD32)
    • DOI 10.1128/JVI.00792-06
    • RodrigoWW, Jin X, Blackley SD, Rose RC, Schlesinger JJ. 2006. Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human FcγRIA (CD64) or FcγRIIA (CD32). J. Virol. 80:10128-38 . (Pubitemid 44522606)
    • (2006) Journal of Virology , vol.80 , Issue.20 , pp. 10128-10138
    • Rodrigo, W.W.S.I.1    Jin, X.2    Blackley, S.D.3    Rose, R.C.4    Schlesinger, J.J.5
  • 153
    • 73149121891 scopus 로고    scopus 로고
    • Involvement of the Fcγreceptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection
    • MoiML, Lim CK, Takasaki T, Kurane I. 2010. Involvement of the Fcγreceptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection. J. Gen. Virol. 91:103-11 .
    • (2010) J. Gen. Virol. , vol.91 , pp. 103-11
    • Moi, M.L.1    Lim, C.K.2    Takasaki, T.3    Kurane, I.4
  • 156
    • 0025785377 scopus 로고
    • Development of cross-reactive antibodies to plasminogen during the immune response to dengue virus infection
    • Markoff LJ, Innis BL, Houghten R, Henchal LS. 1991. Development of cross-reactive antibodies to plasminogen during the immune response to dengue virus infection. J. Infect. Dis. 164:294-301 .
    • (1991) J. Infect. Dis. , vol.164 , pp. 294-301
    • Markoff, L.J.1    Innis, B.L.2    Houghten, R.3    Henchal, L.S.4
  • 157
    • 0028143528 scopus 로고
    • Correlation between detection of plasminogen cross-reactive antibodies and hemorrhage in dengue virus infection
    • Chungue E, Poli L, Roche C, Gestas P, Glaziou P, Markoff LJ. 1994. Correlation between detection of plasminogen cross-reactive antibodies and hemorrhage in dengue virus infection. J. Infect. Dis. 170:1304-7 . (Pubitemid 24328643)
    • (1994) Journal of Infectious Diseases , vol.170 , Issue.5 , pp. 1304-1307
    • Chungue, E.1    Poli, L.2    Roche, C.3    Gestas, P.4    Glaziou, P.5    Markoff, L.J.6
  • 163
    • 77954066120 scopus 로고    scopus 로고
    • Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and e proteins
    • Wang PG, Kudelko M, Lo J, Siu LY, Kwok KT, et al. 2009. Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins. PLoS ONE 4:e8325 .
    • (2009) PLoS ONE , vol.4
    • Wang, P.G.1    Kudelko, M.2    Lo, J.3    Siu, L.Y.4    Kwok, K.T.5
  • 164
    • 0037081397 scopus 로고    scopus 로고
    • Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine
    • DOI 10.1016/S0264-410X(01)00446-7, PII S0264410X01004467
    • Konishi E, Fujii A. 2002. Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine. Vaccine 20:1058-67 . (Pubitemid 34135941)
    • (2002) Vaccine , vol.20 , Issue.7-8 , pp. 1058-1067
    • Konishi, E.1    Fujii, A.2
  • 165
    • 77149169735 scopus 로고    scopus 로고
    • Recombinant dengue virus-like particles from Pichia pastoris: Efficient production and immunological properties
    • Liu W, Jiang H, Zhou J, Yang X, Tang Y, et al. 2010. Recombinant dengue virus-like particles from Pichia pastoris: efficient production and immunological properties. Virus Genes 40:53-59 .
    • (2010) Virus Genes , vol.40 , pp. 53-59
    • Liu, W.1    Jiang, H.2    Zhou, J.3    Yang, X.4    Tang, Y.5
  • 166
    • 47049129455 scopus 로고    scopus 로고
    • A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus
    • DOI 10.1128/JVI.02724-07
    • Raviprakash K, Wang D, Ewing D, Holman DH, Block K, et al. 2008. A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus. J. Virol. 82:6927-34 . (Pubitemid 351977713)
    • (2008) Journal of Virology , vol.82 , Issue.14 , pp. 6927-6934
    • Raviprakash, K.1    Wang, D.2    Ewing, D.3    Holman, D.H.4    Block, K.5    Woraratanadharm, J.6    Chen, L.7    Hayes, C.8    Dong, J.Y.9    Porter, K.10
  • 167
    • 0028039833 scopus 로고
    • Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice
    • DOI 10.1016/0264-410X(94)90206-2
    • Fonseca BAL, Pincus S, Shope RE, Paoletti E, Mason PW. 1994. Recombinant vaccinia viruses coexpressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice. Vaccine 12:279-85 . (Pubitemid 24062530)
    • (1994) Vaccine , vol.12 , Issue.3 , pp. 279-285
    • Fonseca, B.A.L.1    Pincus, S.2    Shope, R.E.3    Paoletti, E.4    Mason, P.W.5
  • 168
    • 34648822387 scopus 로고    scopus 로고
    • An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice
    • DOI 10.1128/JVI.00512-07
    • White LJ, Parsons MM, Whitmore AC, Williams BM, de Silva A, Johnston RE. 2007. An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice. J. Virol. 81:10329-39 . (Pubitemid 47463308)
    • (2007) Journal of Virology , vol.81 , Issue.19 , pp. 10329-10339
    • White, L.J.1    Parsons, M.M.2    Whitmore, A.C.3    Williams, B.M.4    De Silva, A.5    Johnston, R.E.6
  • 169
    • 58149302857 scopus 로고    scopus 로고
    • ADNA vaccine candidate expressing dengue-3 virus prM and e proteins elicits neutralizing antibodies and protectsmice against lethal challenge
    • De Paula SO, Lima DM, deOliveira Franca RF, Gomes-Ruiz AC, da Fonseca BA. 2008. ADNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protectsmice against lethal challenge. Arch. Virol. 153:2215-23 .
    • (2008) Arch. Virol. , vol.153 , pp. 2215-23
    • De Paula, S.O.1    Lima, D.M.2    De Oliveira Franca, R.F.3    Gomes-Ruiz, A.C.4    Da Fonseca, B.A.5
  • 170
    • 32844464015 scopus 로고    scopus 로고
    • Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice
    • DOI 10.1016/j.vaccine.2005.11.002, PII S0264410X05011254
    • Konishi E, Kosugi S, Imoto J. 2006. Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice. Vaccine 24:2200-7 . (Pubitemid 43255164)
    • (2006) Vaccine , vol.24 , Issue.12 , pp. 2200-2207
    • Konishi, E.1    Kosugi, S.2    Imoto, J.-I.3
  • 171
    • 32344434199 scopus 로고    scopus 로고
    • Evaluation of immunity and protective efficacy of a dengue-3 premembrane and envelope DNA vaccine in Aotus nancymae monkeys
    • DOI 10.1016/j.vaccine.2005.09.032, PII S0264410X05009771
    • Blair PJ, Kochel TJ, Raviprakash K, Guevara C, Salazar M, et al. 2006. Evaluation of immunity and protective efficacy of a dengue-3 premembrane and envelopeDNAvaccine in Aotus nancymae monkeys. Vaccine 24:1427-32 . (Pubitemid 43222054)
    • (2006) Vaccine , vol.24 , Issue.9 , pp. 1427-1432
    • Blair, P.J.1    Kochel, T.J.2    Raviprakash, K.3    Guevara, C.4    Salazar, M.5    Wu, S.-J.6    Olson, J.G.7    Porter, K.R.8
  • 173
    • 0034101295 scopus 로고    scopus 로고
    • Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein
    • PII S0264410X99005708
    • Raviprakash K, Kochel TJ, Ewing D, Simmons M, Phillips I, et al. 2000. Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein. Vaccine 18:2426-34 . (Pubitemid 30156814)
    • (2000) Vaccine , vol.18 , Issue.22 , pp. 2426-2434
    • Raviprakash, K.1    Kochel, T.J.2    Ewing, D.3    Simmons, M.4    Phillips, I.5    Hayes, C.G.6    Porter, K.R.7
  • 174
    • 0142216449 scopus 로고    scopus 로고
    • Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys
    • DOI 10.1016/S0042-6822(03)00542-7
    • Raviprakash K, Ewing D, Simmons M, Porter KR, Jones TR, et al. 2003. Needle-free biojector injection of a dengue virus type 1DNAvaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys. Virology 315:345-52 . (Pubitemid 37324624)
    • (2003) Virology , vol.315 , Issue.2 , pp. 345-352
    • Raviprakash, K.1    Ewing, D.2    Simmons, M.3    Porter, K.R.4    Jones, T.R.5    Hayes, C.G.6    Stout, R.7    Murphy, G.S.8
  • 175
    • 35448983219 scopus 로고    scopus 로고
    • A heterologous DNA prime-Venezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaques
    • DOI 10.1128/JVI.00996-07
    • Chen L, Ewing D, Subramanian H, Block K, Rayner J, et al. 2007. A heterologous DNA prime- Venezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaques. J. Virol. 81:11634-39 . (Pubitemid 47623795)
    • (2007) Journal of Virology , vol.81 , Issue.21 , pp. 11634-11639
    • Chen, L.1    Ewing, D.2    Subramanian, H.3    Block, K.4    Rayner, J.5    Alterson, K.D.6    Sedegah, M.7    Hayes, C.8    Porter, K.9    Raviprakash, K.10
  • 176
    • 0242660231 scopus 로고    scopus 로고
    • Replication-Defective Adenoviral Vaccine Vector for the Induction of Immune Responses to Dengue Virus Type 2
    • DOI 10.1128/JVI.77.23.12907-12913.2003
    • Jaiswal S, Khanna N, Swaminathan S. 2003. Replication-defective adenoviral vaccine vector for the induction of immune responses to dengue virus type 2. J. Virol. 77:12907-13 . (Pubitemid 37430686)
    • (2003) Journal of Virology , vol.77 , Issue.23 , pp. 12907-12913
    • Jaiswal, S.1    Khanna, N.2    Swaminathan, S.3
  • 177
    • 0034662389 scopus 로고    scopus 로고
    • Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge
    • PII S0264410X00001213
    • Men R, Wyatt L, Tokimatsu I, Arakaki S, Shameem G, et al. 2000. Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge. Vaccine 18:3113-22 . (Pubitemid 30345693)
    • (2000) Vaccine , vol.18 , Issue.27 , pp. 3113-3122
    • Men, R.1    Wyatt, L.2    Tokimatsu, I.3    Arakaki, S.4    Shameem, G.5    Elkins, R.6    Chanock, R.7    Moss, B.8    Lai, C.-J.9
  • 178
    • 0141594589 scopus 로고    scopus 로고
    • Induction of neutralizing antibodies and partial protection from viral challenge in Macaca fascicularis immunized with recombinant dengue 4 virus envelope glycoprotein expressed in Pichia pastoris
    • Guzman MG, Rodriguez R, Hermida L, Alvarez M, Lazo L, et al. 2003. Induction of neutralizing antibodies and partial protection from viral challenge in Macaca fascicularis immunized with recombinant dengue 4 virus envelope glycoprotein expressed in Pichia pastoris. Am. J. Trop. Med. Hyg. 69:129-34 .
    • (2003) Am. J. Trop. Med. Hyg. , vol.69 , pp. 129-34
    • Guzman, M.G.1    Rodriguez, R.2    Hermida, L.3    Alvarez, M.4    Lazo, L.5
  • 179
    • 0034702096 scopus 로고    scopus 로고
    • Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice
    • PII S0264410X00000323
    • Kelly EP, Greene JJ, King AD, Innis BL. 2000. Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice. Vaccine 18:2549-59 . (Pubitemid 30207040)
    • (2000) Vaccine , vol.18 , Issue.23 , pp. 2549-2559
    • Kelly, E.P.1    Greene, J.J.2    King, A.D.3    Innis, B.L.4
  • 180
    • 77649270249 scopus 로고    scopus 로고
    • Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys
    • Clements DE, Coller BA, Lieberman MM, Ogata S, Wang G, et al. 2010. Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys. Vaccine 28:2705-15 .
    • (2010) Vaccine , vol.28 , pp. 2705-15
    • Clements, D.E.1    Coller, B.A.2    Lieberman, M.M.3    Ogata, S.4    Wang, G.5
  • 181
    • 0030846892 scopus 로고    scopus 로고
    • Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice
    • DOI 10.1016/S0264-410X(97)00128-X, PII S0264410X9700128X
    • Staropoli I, Frenkiel MP, Megret F, Deubel V. 1997. Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice. Vaccine 15:1946-54 . (Pubitemid 27504692)
    • (1997) Vaccine , vol.15 , Issue.17-18 , pp. 1946-1954
    • Staropoli, I.1    Frenkiel, M.-P.2    Megret, F.3    Deubel, V.4
  • 182
    • 31144442443 scopus 로고    scopus 로고
    • Antibodies against West Nile virus nonstructural protein NS1 prevent lethal infection through Fc γ receptor-dependent and -independent mechanisms
    • DOI 10.1128/JVI.80.3.1340-1351.2006
    • Chung KM, Nybakken GE, Thompson BS, Engle MJ, Marri A, et al. 2006. Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fcγ receptor-dependent and -independent mechanisms. J. Virol. 80:1340-51 . (Pubitemid 43134091)
    • (2006) Journal of Virology , vol.80 , Issue.3 , pp. 1340-1351
    • Chung, K.M.1    Nybakken, G.E.2    Thompson, B.S.3    Engle, M.J.4    Marri, A.5    Fremont, D.H.6    Diamond, M.S.7
  • 183
    • 0031926451 scopus 로고    scopus 로고
    • Immunological basis for protection in a murine model of tick-borne encephalitis by a recombinant adenovirus carrying the gene encoding the NS1 non-structural protein
    • Timofeev AV, Ozherelkov SV, Pronin AV, Deeva AV, Karganova GG, et al. 1998. Immunological basis for protection in a murine model of tick-borne encephalitis by a recombinant adenovirus carrying the gene encoding the NS1 nonstructural protein. J. Gen. Virol. 79:689-95 . (Pubitemid 28161941)
    • (1998) Journal of General Virology , vol.79 , Issue.4 , pp. 689-695
    • Timofeev, A.V.1    Ozherelkov, S.V.2    Pronin, A.V.3    Deeva, A.V.4    Karganova, G.G.5    Elbert, L.B.6    Stephenson, J.R.7
  • 184
    • 10744224004 scopus 로고    scopus 로고
    • Evaluation of protective efficacy and immune mechanisms of using a nonstructural protein NS1 inDNAvaccine against dengue 2 virus in mice
    • Wu SF, Liao CL, Lin YL, Yeh CT, Chen LK, et al. 2003. Evaluation of protective efficacy and immune mechanisms of using a nonstructural protein NS1 inDNAvaccine against dengue 2 virus in mice. Vaccine 21:3919-29 .
    • (2003) Vaccine , vol.21 , pp. 3919-29
    • Wu, S.F.1    Liao, C.L.2    Lin, Y.L.3    Yeh, C.T.4    Chen, L.K.5
  • 185
    • 0742269380 scopus 로고    scopus 로고
    • Genetic vaccination of mice with plasmids encoding the ns1 non-structural protein from tick-borne encephalitis virus and dengue 2 virus
    • DOI 10.1023/B:VIRU.0000012266.04871.ce
    • Timofeev AV, Butenko VM, Stephenson JR. 2004. Genetic vaccination of mice with plasmids encoding theNS1 non-structural protein from tick-borne encephalitis virus and dengue 2 virus. Virus Genes 28:85-97 . (Pubitemid 38161272)
    • (2004) Virus Genes , vol.28 , Issue.1 , pp. 85-97
    • Timofeev, A.V.1    Butenko, V.M.2    Stephenson, J.R.3
  • 186
    • 33747108796 scopus 로고    scopus 로고
    • DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus
    • DOI 10.1016/j.vaccine.2005.08.022, PII S0264410X05008194
    • Costa SM, Freire MS, Alves AM. 2006.DNAvaccine against the nonstructural 1 protein (NS1) of dengue 2 virus. Vaccine 24:4562-64 . (Pubitemid 44218840)
    • (2006) Vaccine , vol.24 , Issue.21 , pp. 4562-4564
    • Costa, S.M.1    Freire, M.S.2    Alves, A.M.B.3
  • 187
    • 0025102185 scopus 로고
    • Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis
    • Falgout B, Bray M, Schlesinger JJ, Lai CJ. 1990. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. J. Virol. 64:4356-63 . (Pubitemid 20279846)
    • (1990) Journal of Virology , vol.64 , Issue.9 , pp. 4356-4363
    • Falgout, B.1    Bray, M.2    Schlesinger, J.J.3    Lai, C.-J.4
  • 192
    • 33748300644 scopus 로고    scopus 로고
    • Chimeric West Nile/dengue virus vaccine candidate: Preclinical evaluation in mice, geese and monkeys for safety and immunogenicity
    • DOI 10.1016/j.vaccine.2006.06.008, PII S0264410X06007158
    • Pletnev AG, Swayne DE, Speicher J, Rumyantsev AA, Murphy BR. 2006. Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation inmice, geese and monkeys for safety and immunogenicity. Vaccine 24:6392-404 . (Pubitemid 44331996)
    • (2006) Vaccine , vol.24 , Issue.40-41 , pp. 6392-6404
    • Pletnev, A.G.1    Swayne, D.E.2    Speicher, J.3    Rumyantsev, A.A.4    Murphy, B.R.5
  • 193
    • 0346817393 scopus 로고    scopus 로고
    • Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys
    • DOI 10.1016/S0264-410X(03)00488-2
    • Whitehead SS, Hanley KA, Blaney JE Jr, Gilmore LE, Elkins WR, Murphy BR. 2003. Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys. Vaccine 21:4307-16 . (Pubitemid 37138698)
    • (2003) Vaccine , vol.21 , Issue.27-30 , pp. 4307-4316
    • Whitehead, S.S.1    Hanley, K.A.2    Blaney Jr., J.E.3    Gilmore, L.E.4    Elkins, W.R.5    Murphy, B.R.6
  • 195
    • 75649131888 scopus 로고    scopus 로고
    • A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults
    • Morrison D, Legg TJ, Billings CW, Forrat R, Yoksan S, Lang J. 2010. A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults. J. Infect. Dis. 201:370-77 .
    • (2010) J. Infect. Dis. , vol.201 , pp. 370-77
    • Morrison, D.1    Legg, T.J.2    Billings, C.W.3    Forrat, R.4    Yoksan, S.5    Lang, J.6
  • 196
    • 78650775657 scopus 로고    scopus 로고
    • Live-attenuated tetravalent dengue vaccine in dengue-näve children, adolescents, and adults in Mexico City: Randomized controlled Phase 1 trial of safety and immunogenicity
    • In press
    • Poo J, Galan F, Forrat R, Zambrano B, Lang J, Dayan GH. 2010. Live-attenuated tetravalent dengue vaccine in dengue-nä?ve children, adolescents, and adults in Mexico City: randomized controlled Phase 1 trial of safety and immunogenicity. Pediatr. Infect. Dis. J. In press .
    • (2010) Pediatr. Infect. Dis. J.
    • Poo, J.1    Galan, F.2    Forrat, R.3    Zambrano, B.4    Lang, J.5    Dayan, G.H.6
  • 197
    • 70349576213 scopus 로고    scopus 로고
    • Recent progress on Sanofi Pasteur's dengue vaccine candidate
    • Lang J. 2009. Recent progress on Sanofi Pasteur's dengue vaccine candidate. J. Clin. Virol. 46(Suppl. 2):S20-24 .
    • (2009) J. Clin. Virol. , vol.46 , Issue.SUPPL. 2
    • Lang, J.1
  • 199
    • 0029893436 scopus 로고    scopus 로고
    • Dengue type 4 virusmutants containing deletions in the 3 noncoding region of the RNA genome: Analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys
    • Men R, Bray M, Clark D, Chanock RM, Lai CJ. 1996. Dengue type 4 virusmutants containing deletions in the 3 noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys. J. Virol. 70:3930-37 .
    • (1996) J. Virol. , vol.70 , pp. 3930-37
    • Men, R.1    Bray, M.2    Clark, D.3    Chanock, R.M.4    Lai, C.J.5
  • 202
    • 55849093621 scopus 로고    scopus 로고
    • Phase i clinical evaluation of rDEN4 30-200, 201: A live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity
    • McArthur JH, Durbin AP, Marron JA, Wanionek KA, Thumar B, et al. 2008. Phase I clinical evaluation of rDEN4 30-200, 201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity. Am. J. Trop. Med. Hyg. 79:678-84 .
    • (2008) Am. J. Trop. Med. Hyg. , vol.79 , pp. 678-84
    • McArthur, J.H.1    Durbin, A.P.2    Marron, J.A.3    Wanionek, K.A.4    Thumar, B.5
  • 207
    • 38349050191 scopus 로고    scopus 로고
    • Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3 untranslated region (3-UTR) or by exchange of the DENV-3 3-UTR with that of DENV-4
    • Blaney JE Jr, Sathe NS, Goddard L, Hanson CT, Romero TA, et al. 2008. Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3 untranslated region (3-UTR) or by exchange of the DENV-3 3-UTR with that of DENV-4. Vaccine 26:817-28 .
    • (2008) Vaccine , vol.26 , pp. 817-28
    • Blaney Jr., J.E.1    Sathe, N.S.2    Goddard, L.3    Hanson, C.T.4    Romero, T.A.5
  • 208
    • 0004250845 scopus 로고    scopus 로고
    • Philadelphia Lippincott Williams, Wilkins
    • Knipe DM, Mowley PM, eds. 2001. Fields Virology. Philadelphia: Lippincott, Williams, Wilkins .
    • (2001) Fields Virology
    • Knipe, D.M.1    Mowley, P.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.